Portage Biotech Inc. (PRTG)

USD 7.9

(-12.61%)

Annual Income Statements

(In USD)
Breakdown 2024 2023 2022 2021 2020 2019
Revenue - - - - - -
Cost of Revenue 54 Thousand 1000.00 - - - -
Gross Profit -54 Thousand -1000.00 - - - -
Operating Expenses 18.19 Million 16.57 Million 15.58 Million 12.44 Million 5.97 Million 2.76 Million
Selling, General and Administrative Expenses 5.66 Million 8.36 Million 8.81 Million 5.12 Million 1.87 Million 1.86 Million
Research and Development Expenses 12.53 Million 8.21 Million 6.76 Million 7.31 Million 4.1 Million 762 Thousand
Other Expenses - - - -1.25 Million - 134 Thousand
Cost and Expenses 18.25 Million 16.57 Million 15.58 Million 12.44 Million 5.97 Million 2.76 Million
Operating Income -18.25 Million -16.57 Million -15.58 Million -12.44 Million -5.97 Million -2.76 Million
Interest Expense 32 Thousand 9000.00 43 Thousand 177 Thousand 557 Thousand 88 Thousand
Income Tax Expense -10.54 Million -17.85 Million 4.35 Million 2.29 Million 2.16 Million -217 Thousand
Earnings before Tax -85.69 Million -122.52 Million -14.81 Million -14.89 Million -5.08 Million -3.59 Million
Net Income -75.33 Million -104.61 Million -19.16 Million -17.18 Million -7.24 Million -2.63 Million
Earnings Per Share Basic -3.70 -6.49 -1.47 -1.47 -0.66 -0.55
Earnings Per Share Diluted -3.70 -6.49 -1.47 -1.47 -0.66 -0.55
Weighted Average Shares Outstanding 20.34 Million 16.11 Million 13.06 Million 11.73 Million 10.95 Million 4.81 Million
Weighted Average Shares Outstanding (Diluted) 20.34 Million 16.11 Million 13.06 Million 11.73 Million 10.95 Million 4.82 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -18.19 Million -15.77 Million - - - -650 Thousand
Earnings Before Tax Margin - - - - - -

Income Statement Charts